Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 118

1.

Reply to: Clinical impact of high platelet count and high hematocrit, by Marc Sorigue.

Warny M, Helby J, Birgens HS, Bojesen SE, Nordestgaard BG.

J Thromb Haemost. 2020 Feb;18(2):522-523. doi: 10.1111/jth.14711. No abstract available.

PMID:
31999057
2.

Incidental lymphopenia and mortality: a prospective cohort study.

Warny M, Helby J, Nordestgaard BG, Birgens H, Bojesen SE.

CMAJ. 2020 Jan 13;192(2):E25-E33. doi: 10.1503/cmaj.191024.

PMID:
31932337
3.

Arterial and venous thrombosis by high platelet count and high hematocrit: 108 521 individuals from the Copenhagen General Population Study.

Warny M, Helby J, Birgens HS, Bojesen SE, Nordestgaard BG.

J Thromb Haemost. 2019 Nov;17(11):1898-1911. doi: 10.1111/jth.14574. Epub 2019 Aug 20.

PMID:
31309714
4.

Investigating macrophage-mediated inflammation in migraine using ultrasmall superparamagnetic iron oxide-enhanced 3T magnetic resonance imaging.

Khan S, Amin FM, Fliedner FP, Christensen CE, Tolnai D, Younis S, Olinger ACR, Birgens H, Daldrup-Link H, Kjær A, Larsson HBW, Lindberg U, Ashina M.

Cephalalgia. 2019 Oct;39(11):1407-1420. doi: 10.1177/0333102419848122. Epub 2019 May 19.

PMID:
31104505
5.

Bone marrow mononuclear cell telomere length in acute myeloid leukaemia and high-risk myelodysplastic syndrome.

Warny M, Helby J, Sengeløv H, Nordestgaard BG, Birgens H, Bojesen SE.

Eur J Haematol. 2019 Mar;102(3):218-226. doi: 10.1111/ejh.13196. Epub 2019 Jan 22.

PMID:
30427547
6.

Lymphopenia and risk of infection and infection-related death in 98,344 individuals from a prospective Danish population-based study.

Warny M, Helby J, Nordestgaard BG, Birgens H, Bojesen SE.

PLoS Med. 2018 Nov 1;15(11):e1002685. doi: 10.1371/journal.pmed.1002685. eCollection 2018 Nov.

7.

Results of NOPHO ALL2008 treatment for patients aged 1-45 years with acute lymphoblastic leukemia.

Toft N, Birgens H, Abrahamsson J, Griškevičius L, Hallböök H, Heyman M, Klausen TW, Jónsson ÓG, Palk K, Pruunsild K, Quist-Paulsen P, Vaitkeviciene G, Vettenranta K, Åsberg A, Frandsen TL, Marquart HV, Madsen HO, Norén-Nyström U, Schmiegelow K.

Leukemia. 2018 Mar;32(3):606-615. doi: 10.1038/leu.2017.265. Epub 2017 Aug 18.

PMID:
28819280
8.

Bendamustine plus rituximab for chronic cold agglutinin disease: results of a Nordic prospective multicenter trial.

Berentsen S, Randen U, Oksman M, Birgens H, Tvedt THA, Dalgaard J, Galteland E, Haukås E, Brudevold R, Sørbø JH, Næss IA, Malecka A, Tjønnfjord GE.

Blood. 2017 Jul 27;130(4):537-541. doi: 10.1182/blood-2017-04-778175. Epub 2017 May 22.

PMID:
28533306
9.

Multimodal intervention integrated into the clinical management of acute leukemia improves physical function and quality of life during consolidation chemotherapy: a randomized trial 'PACE-AL'.

Jarden M, Møller T, Christensen KB, Kjeldsen L, Birgens HS, Adamsen L.

Haematologica. 2016 Jul;101(7):e316-9. doi: 10.3324/haematol.2015.140152. Epub 2016 Apr 1. No abstract available.

10.

[Severe haemolysis caused by Mycoplasma pneumoniae].

Bohr AL, Aagaard TG, Birgens H, Søborg C.

Ugeskr Laeger. 2015 Oct 9;177(43):V03150207. Danish.

PMID:
26509456
11.

Severe G6PD Deficiency Due to a New Missense Mutation in an Infant of Northern European Descent.

Warny M, Lausen B, Birgens H, Knabe N, Petersen J.

J Pediatr Hematol Oncol. 2015 Nov;37(8):e497-9. doi: 10.1097/MPH.0000000000000435.

PMID:
26479991
12.

Novel 31.2 kb α0 Deletion in a Palestinian Family with α-Thalassemia.

Brieghel C, Birgens H, Frederiksen H, Hertz JM, Steenhof M, Petersen J.

Hemoglobin. 2015;39(5):346-9. doi: 10.3109/03630269.2015.1054512. Epub 2015 Jun 26.

PMID:
26114741
13.

Haemostatic function and biomarkers of endothelial damage before and after platelet transfusion in patients with acute myeloid leukaemia.

Larsen AM, Leinøe EB, Johansson PI, Larsen R, Wantzin P, Birgens H, Ostrowski SR.

Transfus Med. 2015 Jun;25(3):174-83. doi: 10.1111/tme.12209. Epub 2015 Jun 5.

PMID:
26043955
14.

Prevalence of glucose-6-phosphate dehydrogenase deficiency and diagnostic challenges in 1500 immigrants in Denmark examined for haemoglobinopathies.

Warny M, Klausen TW, Petersen J, Birgens H.

Scand J Clin Lab Invest. 2015 Sep;75(5):390-7. doi: 10.3109/00365513.2015.1031692. Epub 2015 Apr 30.

PMID:
25925739
15.

Toxicity profile and treatment delays in NOPHO ALL2008-comparing adults and children with Philadelphia chromosome-negative acute lymphoblastic leukemia.

Toft N, Birgens H, Abrahamsson J, Griškevičius L, Hallböök H, Heyman M, Klausen TW, Jónsson ÓG, Palk K, Pruunsild K, Quist-Paulsen P, Vaitkeviciene G, Vettenranta K, Asberg A, Helt LR, Frandsen T, Schmiegelow K.

Eur J Haematol. 2016 Feb;96(2):160-9. doi: 10.1111/ejh.12562. Epub 2015 Apr 24.

PMID:
25867866
16.

Haemostatic function and biomarkers of endothelial damage before and after RBC transfusion in patients with haematologic disease.

Larsen AM, Leinøe EB, Johansson PI, Birgens H, Ostrowski SR.

Vox Sang. 2015 Jul;109(1):52-61. doi: 10.1111/vox.12249. Epub 2015 Mar 6.

PMID:
25754541
17.

JAK2V617F somatic mutation in the general population: myeloproliferative neoplasm development and progression rate.

Nielsen C, Bojesen SE, Nordestgaard BG, Kofoed KF, Birgens HS.

Haematologica. 2014 Sep;99(9):1448-55. doi: 10.3324/haematol.2014.107631. Epub 2014 Jun 6.

18.

Need for reclassification of diabetes secondary to iron overload in the ADA and WHO classifications.

Ellervik C, Birgens H, Mandrup-Poulsen T.

Diabetes Care. 2014 Jun;37(6):e137-8. doi: 10.2337/dc14-0119. No abstract available.

PMID:
24855170
19.

Hereditary xerocytosis and familial haemolysis due to mutation in the PIEZO1 gene: a simple diagnostic approach.

Sandberg MB, Nybo M, Birgens H, Frederiksen H.

Int J Lab Hematol. 2014 Aug;36(4):e62-5. doi: 10.1111/ijlh.12172. Epub 2013 Dec 6. No abstract available.

PMID:
24314002
20.

Complying with the European Clinical Trials directive while surviving the administrative pressure - an alternative approach to toxicity registration in a cancer trial.

Frandsen TL, Heyman M, Abrahamsson J, Vettenranta K, Åsberg A, Vaitkeviciene G, Pruunsild K, Toft N, Birgens H, Hallböök H, Quist-Paulsen P, Griškevičius L, Helt L, Hansen BV, Schmiegelow K.

Eur J Cancer. 2014 Jan;50(2):251-9. doi: 10.1016/j.ejca.2013.09.027. Epub 2013 Nov 11.

PMID:
24231337
21.

Patient Activation through Counseling and Exercise--Acute Leukemia (PACE-AL)--a randomized controlled trial.

Jarden M, Møller T, Kjeldsen L, Birgens H, Christensen JF, Bang Christensen K, Diderichsen F, Hendriksen C, Adamsen L.

BMC Cancer. 2013 Oct 2;13:446. doi: 10.1186/1471-2407-13-446.

22.

A phase III randomized trial comparing glucocorticoid monotherapy versus glucocorticoid and rituximab in patients with autoimmune haemolytic anaemia.

Birgens H, Frederiksen H, Hasselbalch HC, Rasmussen IH, Nielsen OJ, Kjeldsen L, Larsen H, Mourits-Andersen T, Plesner T, Rønnov-Jessen D, Vestergaard H, Klausen TW, Schöllkopf C.

Br J Haematol. 2013 Nov;163(3):393-9. doi: 10.1111/bjh.12541. Epub 2013 Aug 24.

PMID:
23981017
23.

Total mortality by elevated transferrin saturation in patients with diabetes.

Ellervik C, Andersen HU, Tybjærg-Hansen A, Frandsen M, Birgens H, Nordestgaard BG, Mandrup-Poulsen T.

Diabetes Care. 2013 Sep;36(9):2646-54. doi: 10.2337/dc12-2032. Epub 2013 Jun 25.

24.

High syndecan-1 levels in acute myeloid leukemia are associated with bleeding, thrombocytopathy, endothelial cell damage, and leukocytosis.

Larsen AM, Leinøe EB, Johansson PI, Birgens H, Ostrowski SR.

Leuk Res. 2013 Jul;37(7):777-83. doi: 10.1016/j.leukres.2013.02.015. Epub 2013 Apr 6.

PMID:
23570784
25.

Risk group assignment differs for children and adults 1-45 yr with acute lymphoblastic leukemia treated by the NOPHO ALL-2008 protocol.

Toft N, Birgens H, Abrahamsson J, Bernell P, Griškevičius L, Hallböök H, Heyman M, Holm MS, Hulegårdh E, Klausen TW, Marquart HV, Jónsson OG, Nielsen OJ, Quist-Paulsen P, Taskinen M, Vaitkeviciene G, Vettenranta K, Åsberg A, Schmiegelow K.

Eur J Haematol. 2013 May;90(5):404-12. doi: 10.1111/ejh.12097. Epub 2013 Apr 2.

PMID:
23461707
26.

Measuring the impact of a restrictive transfusion guideline in patients with acute myeloid leukaemia.

Hoeg RT, Leinoe EB, Andersen P, Klausen TW, Birgens HS.

Vox Sang. 2013 Jul;105(1):81-4. doi: 10.1111/vox.12017. Epub 2013 Feb 1.

PMID:
23368963
27.

Rituximab and dexamethasone vs dexamethasone monotherapy in newly diagnosed patients with primary immune thrombocytopenia.

Gudbrandsdottir S, Birgens HS, Frederiksen H, Jensen BA, Jensen MK, Kjeldsen L, Klausen TW, Larsen H, Mourits-Andersen HT, Nielsen CH, Nielsen OJ, Plesner T, Pulczynski S, Rasmussen IH, Rønnov-Jessen D, Hasselbalch HC.

Blood. 2013 Mar 14;121(11):1976-81. doi: 10.1182/blood-2012-09-455691. Epub 2013 Jan 4.

PMID:
23293082
28.

Diagnostic value of JAK2 V617F somatic mutation for myeloproliferative cancer in 49 488 individuals from the general population.

Nielsen C, Birgens HS, Nordestgaard BG, Bojesen SE.

Br J Haematol. 2013 Jan;160(1):70-9. doi: 10.1111/bjh.12099. Epub 2012 Nov 1.

PMID:
23116358
29.

The emerging role of exercise and health counseling in patients with acute leukemia undergoing chemotherapy during outpatient management.

Jarden M, Adamsen L, Kjeldsen L, Birgens H, Tolver A, Christensen JF, Stensen M, Sørensen VA, Møller T.

Leuk Res. 2013 Feb;37(2):155-61. doi: 10.1016/j.leukres.2012.09.001. Epub 2012 Sep 27.

PMID:
23021021
30.

Adult acute lymphoblastic leukaemia in Denmark. A national population-based retrospective study on acute lymphoblastic leukaemia in Denmark 1998-2008.

Toft N, Schmiegelow K, Klausen TW, Birgens H.

Br J Haematol. 2012 Apr;157(1):97-104. doi: 10.1111/j.1365-2141.2011.09020.x. Epub 2012 Jan 11.

PMID:
22233128
31.

Elevated transferrin saturation and risk of diabetes: three population-based studies.

Ellervik C, Mandrup-Poulsen T, Andersen HU, Tybjærg-Hansen A, Frandsen M, Birgens H, Nordestgaard BG.

Diabetes Care. 2011 Oct;34(10):2256-8. doi: 10.2337/dc11-0416. Epub 2011 Aug 26.

32.

Risk of thyroid cancer, brain cancer, and non-Hodgkin lymphoma after adult leukemia: a nationwide study.

Nielsen SF, Bojesen SE, Birgens HS, Nordestgaard BG.

Blood. 2011 Oct 13;118(15):4062-9. doi: 10.1182/blood-2011-02-337170. Epub 2011 Aug 12.

PMID:
21841167
33.

[Eculizumab in paroxysmal nocturnal hemoglobinuria].

Birgens H.

Ugeskr Laeger. 2011 Mar 7;173(10):714. Danish. No abstract available.

PMID:
21375975
34.

[The pathogenesis of primary immune thrombocytopenia].

Gudbrandsdottir S, Frederiksen H, Birgens HS, Nielsen CH, Nielsen OJ, Stentoft J, Hasselbalch HC.

Ugeskr Laeger. 2011 Jan 24;173(4):274-7. Danish.

PMID:
21262172
35.

[New treatment options for primary immune thrombocytopenia].

Gudbrandsdottir S, Frederiksen H, Birgens HS, Nielsen CH, Nielsen OJ, Stentoft J, Hasselbalch HC.

Ugeskr Laeger. 2011 Jan 24;173(4):271-4. Danish.

PMID:
21262171
36.

The JAK2 V617F somatic mutation, mortality and cancer risk in the general population.

Nielsen C, Birgens HS, Nordestgaard BG, Kjaer L, Bojesen SE.

Haematologica. 2011 Mar;96(3):450-3. doi: 10.3324/haematol.2010.033191. Epub 2010 Dec 15.

37.

A dominant mutation in the gene encoding the erythroid transcription factor KLF1 causes a congenital dyserythropoietic anemia.

Arnaud L, Saison C, Helias V, Lucien N, Steschenko D, Giarratana MC, Prehu C, Foliguet B, Montout L, de Brevern AG, Francina A, Ripoche P, Fenneteau O, Da Costa L, Peyrard T, Coghlan G, Illum N, Birgens H, Tamary H, Iolascon A, Delaunay J, Tchernia G, Cartron JP.

Am J Hum Genet. 2010 Nov 12;87(5):721-7. doi: 10.1016/j.ajhg.2010.10.010. Epub 2010 Nov 4.

38.

Further studies on Hb Canebière [β12(G4)Asn→His], a low affinity hemoglobin variant.

Froelund U, Sandbakken E, Szecsi P, Birgens H.

Hemoglobin. 2010;34(5):495-9. doi: 10.3109/03630269.2010.511593.

PMID:
20854124
39.

Vitamin B12 deficiency in a 15-year old boy due to mutations in the intrinsic factor gene, GIF.

Overgaard UM, Tanner SM, Birgens HS.

Br J Haematol. 2010 Aug;150(3):369-71. doi: 10.1111/j.1365-2141.2010.08198.x. Epub 2010 Apr 12. No abstract available.

40.

[Flowcytometric diagnostics of hereditary spherocytosis].

Riley CH, Nikolajsen K, Kjaersgaard E, Klausen TW, Mourits-Andersen T, Clausen N, Lausen B, Rosthøj S, Birgens H.

Ugeskr Laeger. 2009 Nov 30;171(49):3610-4. Danish.

PMID:
19954702
41.

Microfludic device for creating ionic strength gradients over DNA microarrays for efficient DNA melting studies and assay development.

Petersen J, Poulsen L, Birgens H, Dufva M.

PLoS One. 2009;4(3):e4808. doi: 10.1371/journal.pone.0004808. Epub 2009 Mar 11.

42.

[Novel medical treatment modalities in hematology].

Hasselbalch HC, Birgens H, Dufva IH, Dalseg AM, Brown Pde N, Jensen MK, Vangsted A.

Ugeskr Laeger. 2008 Jun 9;170(24):2115-9. Review. Danish.

PMID:
18565291
43.

Pinched flow fractionation devices for detection of single nucleotide polymorphisms.

Larsen AV, Poulsen L, Birgens H, Dufva M, Kristensen A.

Lab Chip. 2008 May;8(5):818-21. doi: 10.1039/b802268b. Epub 2008 Mar 19.

PMID:
18432355
44.

Use of a multi-thermal washer for DNA microarrays simplifies probe design and gives robust genotyping assays.

Petersen J, Poulsen L, Petronis S, Birgens H, Dufva M.

Nucleic Acids Res. 2008 Feb;36(2):e10. Epub 2007 Dec 6.

45.

Hemochromatosis genotypes and risk of 31 disease endpoints: meta-analyses including 66,000 cases and 226,000 controls.

Ellervik C, Birgens H, Tybjaerg-Hansen A, Nordestgaard BG.

Hepatology. 2007 Oct;46(4):1071-80.

PMID:
17828789
46.
47.

Epidemiology of haemoglobin disorders in Europe: an overview.

Modell B, Darlison M, Birgens H, Cario H, Faustino P, Giordano PC, Gulbis B, Hopmeier P, Lena-Russo D, Romao L, Theodorsson E.

Scand J Clin Lab Invest. 2007;67(1):39-69. Review.

PMID:
17365984
48.

The thalassaemia syndromes.

Birgens H, Ljung R.

Scand J Clin Lab Invest. 2007;67(1):11-25. Review.

PMID:
17365982
49.

Haemoglobinopathies and glucose-6-phosphate dehydrogenase deficiency in a Scandinavian perspective.

Theodorsson E, Birgens H, Hagve TA.

Scand J Clin Lab Invest. 2007;67(1):3-10. Review.

PMID:
17365981
50.

Detection of mutations in the beta-globin gene by colorimetric staining of DNA microarrays visualized by a flatbed scanner.

Petersen J, Stangegaard M, Birgens H, Dufva M.

Anal Biochem. 2007 Jan 1;360(1):169-71. Epub 2006 Sep 7. No abstract available.

PMID:
16996468

Supplemental Content

Loading ...
Support Center